Choices and Experiences Around Closed-loop Therapy in Type 1 Diabetes

Overview

Type 1 diabetes requires a lot of work to try to keep glucose levels in the target range. Hybrid closed- loop, also known as artificial pancreas, takes glucose readings from a sensor (continuous glucose monitor) and uses an algorithm to tell an insulin pump how much insulin to deliver. Hybrid closed-loop has currently been rolled out to many people with type 1 diabetes in England. We are keen to develop a deeper understanding of the perspective of people living with type 1 diabetes who have choices about which hybrid closed-loop systems fit their needs. The main purpose of this study is to explore the choices and experiences of people living with type 1 diabetes regarding closed-loop therapy.

This is a cross-sectional online survey study, which involves people with type 1 diabetes who use closed-loop, wait to start closed-loop or considering closed-loop. The primary objective of the study is to explore the factors driving the choices of people living with type 1 diabetes regarding closed-loop therapy. The secondary objectives of the study are: * To understand what treatment satisfaction with closed-loop therapy means to people living with type 1 diabetes * To understand what additional support is needed for people with type 1 diabetes using closed-loop therapy

Conditions

Eligibility